key: cord-0727766-7xg7h05d
authors: Fischell, Stefanie Zaner; Fischell, Jonathan M.; Olexa, Gloribel; Callahan, Charles; Bollinger, Mary E.
title: Impact of COVID-19 pandemic on frequency and severity of asthma exacerbations in an inner-city population
date: 2021-12-16
journal: Ann Allergy Asthma Immunol
DOI: 10.1016/j.anai.2021.12.012
sha: f126ae3e0facf8ea93d3c2e4ec5b6b3164298bb5
doc_id: 727766
cord_uid: 7xg7h05d

nan

The COVID-19 pandemic profoundly altered the way that society functioned with resultant shifts in behavior and exposures, particularly when the national shelter in place orders were implemented in mid-March 2020. These changes may have significantly impacted patients with chronic diseases including asthma, which disproportionately affects underserved minority children 1 . In addition to changes in exposures such as viruses and environmental triggers, changes in healthcare access and utilization impact asthma morbidity [2] [3] [4] [5] [6] [7] . Initially, it was unclear if these changes would have a positive or negative impact on children with asthma 5 . Over the past year, several studies have reported a significant reduction in Emergency Department (ED) visits for pediatric asthma throughout the United States 7-9 .

The current study sought to evaluate the impact of the COVID-19 pandemic on ED visits and hospitalizations in an inner-city pediatric population with specific comparisons of exacerbation severity.

This study was deemed exempt by our Institutional Review Board. Retrospective data was collected from our urban academic hospital to include children presenting to the ED with a diagnosis of -asthma exacerbation‖ (ICD 10 codes J45.901/2, J45.21-25, J45.22-52) as one of the top two diagnoses. Data included patient demographics and final disposition -discharged from the ED, admitted to the general inpatient unit or admitted to the Pediatric Intensive Care Unit (PICU) -as surrogate markers of illness severity. Data was divided into 12-week quarters with quarter 1: January-March, quarter 2: April-June, quarter 3: July-September, and quarter 4:

October-December. The onset of COVID-19 was defined as April 1, 2020 (quarter 2). Pre-COVID-19 data was collected from 2016-2019 and was the average of 48 weeks for each quarter. During-COVID-19 data was the average of 12 weeks for each 2020 quarter. Data collection ended December 2020 (quarter 4). Quarter 1 during-COVID-19 was January-March 2021, thus it was not included in our analysis. The number of ED visits for asthma per week and percentage of patients with each final disposition (ED, inpatient or PICU) was averaged for each pre-and during-COVID-19 quarter. Unpaired T-tests were used to compare the means/week preto during-COVID-19 for each quarter (2) (3) (4) .

The overall study population consisted of 4,664 unique patients. The overall sample had a mean age of 8.2 years with 56.2% male and 89.3% African-American; the remainder selfidentified as either white, multiracial or other. Age, gender and race did not significantly differ pre-and during-COVID-19; although, during-COVID-19 health insurance coverage changed, with 87.3% Medicaid insured pre-and 95.1% during-, 10.7% privately insured pre-and 4.9% during and 2.0% uninsured patients pre-and 0% during-COVID-19.

As shown in Figure 1 , there was a statistically significant decrease in ED presentations for asthma during-COVID-19 vs. pre-COVID-19 in quarter 2 (decreased 87.2%), quarter 3 (73.5%) and quarter 4 (77.3%), (p<0.0001for all.) There was a significant increase in the percentage of patients who did not require any admission (discharged from the ED) during-COVID-19, compared to pre-COVID-19 in quarters 2 (p<0.0001) and 3 (p<0.05), but no difference in quarter 4. There were no significant differences in the percent admitted to the general inpatient unit during-vs. pre-COVID-19 for any quarter. There was a significant reduction in the percentage of patients admitted to the PICU during-COVID-19, in quarter 2 (p<0.0001), a reduction in quarter 3 that approached significance (p=0.056) and no difference in quarter 4.

We found a statistically significant reduction in ED visits for asthma during the pandemic (79.3%), which is higher than other studies (range 45.2%-75%) 8, 9 . We initially hypothesized that the significant reduction in pediatric asthma ED visits was due to reluctance to go to the ED due to concerns of contracting COVID-19. If so, we would expect higher exacerbation severity, resulting in increased PICU admissions and decreased ED discharges. However, we found the opposite. Our study is the first to utilize final disposition (admitted to PICU vs. discharged from the ED) as a marker of asthma exacerbation severity, pre/during-COVID-19. Decreased ED utilization was sustained 9 months after the onset of the pandemic suggesting that the ongoing COVID-19 precautions such as social distancing, distance learning and masks may have contributed to this improvement. Though designed to reduce transmission of SARS-COV-2, these measures could also reduce transmission of other respiratory viruses that are the primary cause of asthma exacerbations 7, 10 . With children and caregivers spending more time at home, other potential contributing factors include changes in indoor allergen exposure from school to home 1 and improved asthma medication adherence 7 .

The percent reduction in PICU asthma admissions is both striking and novel. We found a significant impact in quarter 2, but not 3 or 4. Although data were unavailable to investigate this, possible explanations include reduced adherence to COVID-19 precautions later in the pandemic and seasonal fluctuations in viral prevalence.

One study limitation is that detailed information, including allergen sensitization, exposure data, receipt of specialty care and respiratory viral data were unavailable. Unfortunately, fewer respiratory viral panels were obtained during-COVID-19, limiting our ability to assess specific pre/during viral triggers. Another factor that could impact our results is a change in the threshold for PICU admissions during-COVID-19 due to bed availability. However, we continued to use our standardized asthma pathway admission criteria throughout the pandemic, and there were no PICU bed shortages. Finally, without the availability of comparison data for other diseases, we cannot conclude that COVID-19 measures were specifically only affecting asthma.

In conclusion, we found, in our underserved, minority, inner-city pediatric population, that both the frequency and severity of asthma exacerbations decreased immediately after the onset of the COVID-19 pandemic. Changes in behavior, such as sheltering in place, distance learning and masking to reduce the spread of SARS-CoV-2, had a profound impact on asthma morbidity in our population. These may not be reasonable long-term measures and COVID-19 vaccination of children may change the need for some of them. Further studies may elucidate if any of these measures should be recommended for all or select populations of children to prevent viral illnesses that impact asthma morbidity and mortality.

Explaining Racial Disparities in Child Asthma Readmission Using a Causal Inference Approach

Decreased Influenza Activity During the COVID-19 Pandemic -United States

Evaluation of Seasonal Respiratory Virus Activity Before and After the Statewide COVID-19 Shelter-in-Place Order in Northern California

Impact of COVID-19 on Pediatric Asthma: Practice Adjustments and Disease Burden

Team CC-19 R. Coronavirus Disease 2019 in Children -United States

Monitoring respiratory infections in covid-19 epidemics

Pediatric Asthma Health Care Utilization, Viral Testing, and Air Pollution Changes During the COVID-19 Pandemic

Pediatric emergency department visits at US children's hospitals during the COVID-19 pandemic

Initial effects of the COVID-19 pandemic on pediatric asthma emergency department utilization

Viral infections and associated factors that promote acute exacerbations of asthma

Figure 1 Legend: Frequency and Severity of Pediatric Emergency Department Visits for Asthma Pre and During COVID-19. Average number of patients/week presenting to the Pediatric Emergency Department for asthma exacerbations pre (gray) vs. during (black) COVID-19*. Percentage of patients discharged from the Emergency Department (-ED‖, green), admitted to the general inpatient unit

Covid numbers averaged over 2016-2019 and during-Covid in 2020

Marty Reynolds -Hospital data retrieval